Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuroone Medical Technologies (NMTC) Treasury Shares (2020 - 2026)

Neuroone Medical Technologies filings provide 7 years of Treasury Shares readings, the most recent being $14788.0 for Q1 2026.

  • On a quarterly basis, Treasury Shares fell 5.92% to $14788.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $14788.0, a 5.92% decrease, with the full-year FY2025 number at $812696.0, down 28.06% from a year prior.
  • Treasury Shares hit $14788.0 in Q1 2026 for Neuroone Medical Technologies, up from $680.0 in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $1.1 million in Q3 2024 to a low of $4.08 in Q2 2025.
  • Median Treasury Shares over the past 5 years was $15253.5 (2025), compared with a mean of $208547.2.
  • Biggest five-year swings in Treasury Shares: skyrocketed 3540.46% in 2022 and later plummeted 99.99% in 2025.
  • Neuroone Medical Technologies' Treasury Shares stood at $414430.0 in 2022, then crashed by 97.3% to $11176.0 in 2023, then crashed by 81.43% to $2075.0 in 2024, then crashed by 67.23% to $680.0 in 2025, then soared by 2074.71% to $14788.0 in 2026.
  • The last three reported values for Treasury Shares were $14788.0 (Q1 2026), $680.0 (Q4 2025), and $812696.0 (Q3 2025) per Business Quant data.